** Shares of continuous glucose-monitoring device makers Abbott ABTN and Dexcom DXCM.O rise after U.S. Health Secretary Robert F. Kennedy Jr. stated, "We're about to launch one of the biggest advertising campaigns in HHS (Health and Human Services) history to encourage Americans to use wearables."
** ABT rose 3.5% to $137.94, while DXCM jumped 7.7% to $85.99, in afternoon trading
** "We think that wearables are a key to the MAHA agenda, Making America Healthy Again and my vision is that every American is wearing a wearable within four years" - Kennedy
** Including session moves, ABT and DXCM have gained 22.1% and 10.8%, respectively, YTD
(Reporting by Puyaan Singh)
((Puyaan.Singh@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。